使用术中荧光成像的两阶段假体乳房再造:倾向评分匹配分析
该回顾性研究纳入2011年1月至2020年12月接受全乳切除并即刻两阶段组织扩张器假体乳房再造的患者,经倾向评分匹配后比较术中SPY系统荧光成像评估与临床评估各99例再造的手术结局。荧光成像组30天伤口相关并发症及非计划干预率更低,但血清肿和血肿发生率更高,Wise pattern为早期伤口相关并发症的唯一独立预测因素。
要点
- 匹配后荧光成像组30天伤口相关并发症21% vs 临床评估组9%(P=0.017)。
- 荧光成像组30天伤口相关非计划干预5% vs 临床评估组16%(P=0.011)。
- 荧光成像组血清肿19% vs 14%、血肿8% vs 0%,均高于临床评估组。
核心结论
- 匹配后,荧光成像评估的再造相比单纯临床评估表现出更低的早期伤口相关并发症发生率。
- Wise pattern乳房切除被发现在与早期伤口相关并发症相关的因素中为唯一独立预测因素。
研究设计与样本
- 回顾性研究,纳入2011年1月至2020年12月接受全乳切除并即刻两阶段组织扩张器假体乳房再造的患者。
- 比较术中SPY系统荧光成像评估与临床评估两组,采用倾向评分匹配分析。
- 匹配后共评估198例再造,每组99例。
主要发现
- 组织扩张器至假体交换的中位时间荧光成像组140天 vs 临床评估组185天(P=0.476)。
- 开始辅助放疗的时间荧光成像组144天 vs 临床评估组98天(P=0.199)。
- 30天伤口相关并发症发生率荧光成像组21% vs 临床评估组9%(P=0.017)。
- 30天伤口相关非计划干预率荧光成像组5% vs 临床评估组16%(P=0.011)。
- 30天血清肿发生率荧光成像组19% vs 临床评估组14%(P=0.041),血肿发生率荧光成像组8% vs 临床评估组0%(P=0.004)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Limited comparability between study groups can generate significant selection and observer bias when evaluating the efficacy of the SPY system and fluorescence imaging for implant-based breast reconstruction. In this study, the authors compared the surgical outcomes and complications during the first stage of reconstruction between reconstructions evaluated intraoperatively with fluorescence imaging using the SPY system and clinical assessment using a matched analysis. METHODS: The authors conducted a retrospective review of patients undergoing total mastectomy and immediate two-stage implant-based breast reconstruction with TEs from January of 2011 to December of 2020. The rate of complication, time for TE-to-implant exchange, and time to start radiotherapy were compared between groups (intraoperative fluorescence imaging versus clinical assessment) using a propensity score-matched analysis. RESULTS: After propensity score matching, 198 reconstructions were evaluated. There were 99 reconstructions in each group. The median time for TE-to-implant exchange (140 days versus 185 days; P = 0.476) and time to initiate adjuvant radiotherapy (144 days versus 98 days; P = 0.199) were comparable between groups. The 30-day rate of wound-related complications (21% versus 9%; P = 0.017) and 30-day rate of wound-related unplanned interventions were significantly higher in reconstructions evaluated with clinical assessment when compared with the SPY system (16% versus 5%; P = 0.011). A higher 30-day rate of seroma (19% versus 14%; P = 0.041) and hematoma (8% versus 0%; P = 0.004) were found in reconstructions assessed intraoperatively with the SPY system. CONCLUSIONS: After matching, reconstructions evaluated with fluorescence imaging exhibited a lower incidence of early wound-related complications when compared with clinical evaluation alone. Nonetheless, the Wise pattern for mastectomy was found to be the only independent predictor associated with early wound-related complications. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Escandón JM, Christiano JG, Gooch JC, et al. Two-Stage Implant-Based Breast Reconstruction Using Intraoperative Fluorescence Imaging: A Propensity Score-Matched Analysis. Plast Reconstr Surg. 2023. PMID: 37104496. doi:10.1097/PRS.0000000000010602
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。